Jianjun Zhang, Min Zhao, Fan Wu, Zheng Shi, Rui Xie
{"title":"Inhibition mechanism and behaviour of wedelolactone against α-glucosidase.","authors":"Jianjun Zhang, Min Zhao, Fan Wu, Zheng Shi, Rui Xie","doi":"10.1080/14756366.2025.2551970","DOIUrl":null,"url":null,"abstract":"<p><p>The quest for effective and safe treatments for diabetes mellitus has led to the exploration of natural metabolites as potential α-glucosidase inhibitors. This study delves into the inhibition mechanism of wedelolactone against α-glucosidase and its hypoglycaemic activity. Activity assay results discovered that wedelolactone functioned as a mixed-type inhibitor, with an IC<sub>50</sub> of 39.12 ± 2.54 μM, surpassing the potency of the standard drug acarbose. Employing multi-spectra methods, our findings indicated that wedelolactone binding induced conformation changes in α-glucosidase to attenuate its enzymatic activity, as evidenced by fluorescence quenching, synchronous fluorescence, 3D fluorescence, CD spectra, and ANS assay. Molecular docking studies provided insights into the specific interactions between wedelolactone and α-glucosidase. Collectively, these results laid the groundwork for the potential application of wedelolactone as a natural therapeutic agent in diabetes management.</p>","PeriodicalId":15769,"journal":{"name":"Journal of Enzyme Inhibition and Medicinal Chemistry","volume":"40 1","pages":"2551970"},"PeriodicalIF":5.4000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406323/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Enzyme Inhibition and Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14756366.2025.2551970","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The quest for effective and safe treatments for diabetes mellitus has led to the exploration of natural metabolites as potential α-glucosidase inhibitors. This study delves into the inhibition mechanism of wedelolactone against α-glucosidase and its hypoglycaemic activity. Activity assay results discovered that wedelolactone functioned as a mixed-type inhibitor, with an IC50 of 39.12 ± 2.54 μM, surpassing the potency of the standard drug acarbose. Employing multi-spectra methods, our findings indicated that wedelolactone binding induced conformation changes in α-glucosidase to attenuate its enzymatic activity, as evidenced by fluorescence quenching, synchronous fluorescence, 3D fluorescence, CD spectra, and ANS assay. Molecular docking studies provided insights into the specific interactions between wedelolactone and α-glucosidase. Collectively, these results laid the groundwork for the potential application of wedelolactone as a natural therapeutic agent in diabetes management.
期刊介绍:
Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents.
Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research.
The journal’s focus includes current developments in:
Enzymology;
Cell biology;
Chemical biology;
Microbiology;
Physiology;
Pharmacology leading to drug design;
Molecular recognition processes;
Distribution and metabolism of biologically active compounds.